Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 193

1.

Routine surveillance for the detection of acute and recent HIV infections and transmission of antiretroviral resistance.

Truong HM, Grant RM, McFarland W, Kellogg T, Kent C, Louie B, Wong E, Klausner JD.

AIDS. 2006 Nov 14;20(17):2193-7.

PMID:
17086059
2.

Detection of acute HIV infections in an urban HIV counseling and testing population in the United States.

Priddy FH, Pilcher CD, Moore RH, Tambe P, Park MN, Fiscus SA, Feinberg MB, del Rio C.

J Acquir Immune Defic Syndr. 2007 Feb 1;44(2):196-202.

PMID:
17312561
3.
4.

Transmission of drug-resistant HIV-1 in Europe remains limited to single classes.

SPREAD programme.

AIDS. 2008 Mar 12;22(5):625-35. doi: 10.1097/QAD.0b013e3282f5e062.

PMID:
18317004
5.

Brazilian Network for HIV Drug Resistance Surveillance (HIV-BResNet): a survey of chronically infected individuals.

Brindeiro RM, Diaz RS, Sabino EC, Morgado MG, Pires IL, Brigido L, Dantas MC, Barreira D, Teixeira PR, Tanuri A; Brazilian Network for Drug Resistance Surveillance.

AIDS. 2003 May 2;17(7):1063-9.

PMID:
12700457
6.

HIV incidence among men diagnosed with early syphilis in Atlanta, San Francisco, and Los Angeles, 2004 to 2005.

Buchacz K, Klausner JD, Kerndt PR, Shouse RL, Onorato I, McElroy PD, Schwendemann J, Tambe PB, Allen M, Coye F, Kent Ck, Park MN, Hawkins K, Samoff E, Brooks JT.

J Acquir Immune Defic Syndr. 2008 Feb 1;47(2):234-40.

PMID:
18340654
7.

Rare mutations at codon 103 of HIV-1 reverse transcriptase can confer resistance to non-nucleoside reverse transcriptase inhibitors.

Harrigan PR, Mo T, Wynhoven B, Hirsch J, Brumme Z, McKenna P, Pattery T, Vingerhoets J, Bacheler LT.

AIDS. 2005 Mar 24;19(6):549-54.

PMID:
15802972
8.

Sentinel surveillance of HIV-1 transmitted drug resistance, acute infection and recent infection.

Truong HM, Kellogg TA, McFarland W, Louie B, Klausner JD, Philip SS, Grant RM.

PLoS One. 2011;6(10):e25281. doi: 10.1371/journal.pone.0025281. Epub 2011 Oct 6. Erratum in: PLoS One. 2011;6(11). doi: 10.1371/annotation/69eda582-222c-4993-99a5-733db2dac07c. Truong, Hong-Ha M [corrected to Truong, H M].

9.

Detecting acute human immunodeficiency virus infection using 3 different screening immunoassays and nucleic acid amplification testing for human immunodeficiency virus RNA, 2006-2008.

Patel P, Mackellar D, Simmons P, Uniyal A, Gallagher K, Bennett B, Sullivan TJ, Kowalski A, Parker MM, LaLota M, Kerndt P, Sullivan PS; Centers for Disease Control and Prevention Acute HIV Infection Study Group.

Arch Intern Med. 2010 Jan 11;170(1):66-74. doi: 10.1001/archinternmed.2009.445.

PMID:
20065201
10.

Drug resistance among chronic HIV-1-infected patients naïve for use of anti-retroviral therapy in Sao Paulo city.

Gonsalez CR, Alcalde R, Nishiya A, Barreto CC, Silva FE, de Almeida A, Mendonça M, Ferreira F, Fernandes SS, Casseb J, Duarte AJ.

Virus Res. 2007 Nov;129(2):87-90. Epub 2007 Aug 7.

PMID:
17686543
11.

[Epidemiology of primary drug resistance in chronically HIV-infected patients in Nordrhein-Westfalen, Germany, 2001-2005].

Oette M, Kaiser R, Däumer M, Fätkenheuer G, Rockstroh JK, Knechten H, Mitrenga D, Beerenwinkel N, Sagir A, Pfister H, Häussinger D.

Dtsch Med Wochenschr. 2007 May 4;132(18):977-82. German.

PMID:
17457780
12.

[Primary antiretroviral drug resistance among patients diagnosed with HIV infection in Gran Canaria (Spain) between 2002 and 2005].

Sánchez Oñoro M, López MJ, Santana MA, Andés JM, Campelo FA.

Enferm Infecc Microbiol Clin. 2007 Aug-Sep;25(7):437-40. Spanish.

PMID:
17692211
13.

The prevalence of resistance-associated mutations to protease and reverse transcriptase inhibitors in treatment-naïve (HIV1)-infected individuals in Casablanca, Morocco.

Bakhouch K, Oulad-Lahcen A, Bensghir R, Blaghen M, Elfilali KM, Ezzikouri S, Abidi O, Hassar M, Wakrim L.

J Infect Dev Ctries. 2009 Jun 1;3(5):380-91.

14.

Low prevalence of drug-resistant HIV-1 in patients newly diagnosed with early stage of HIV infection in Korea.

Kim CO, Chin BS, Han SH, Lee HS, Jeong SJ, Choi HK, Choi JY, Song YG, Lee JS, Kim JM.

Tohoku J Exp Med. 2008 Nov;216(3):259-65.

15.
16.

HIV drug resistance threshold survey using specimens from voluntary counselling and testing sites in Hanoi, Vietnam.

Nguyen HT, Duc NB, Shrivastava R, Tran TH, Nguyen TA, Thang PH, McNicholl JM, Leelawiwat W, Chonwattana W, Sidibe K, Fujita M, Luu CM, Kakkar R, Bennett DE, Kaplan J, Cosimi L, Wolfe MI.

Antivir Ther. 2008;13 Suppl 2:115-21.

PMID:
18575200
17.

Transmission of HIV-1 drug resistance in Switzerland: a 10-year molecular epidemiology survey.

Yerly S, von Wyl V, Ledergerber B, Böni J, Schüpbach J, Bürgisser P, Klimkait T, Rickenbach M, Kaiser L, Günthard HF, Perrin L; Swiss HIV Cohort Study.

AIDS. 2007 Oct 18;21(16):2223-9.

PMID:
18090050
18.

Antiretroviral resistance in individuals presenting therapeutic failure and subtypes of the human immunodeficiency virus type 1 in the Northeast Region of Brazil.

Cavalcanti AM, Lacerda HR, Brito AM, Pereira S, Medeiros D, Oliveira S.

Mem Inst Oswaldo Cruz. 2007 Nov;102(7):785-92. Epub 2007 Dec 11.

19.

HIV is hyperendemic among men who have sex with men in San Francisco: 10-year trends in HIV incidence, HIV prevalence, sexually transmitted infections and sexual risk behaviour.

Scheer S, Kellogg T, Klausner JD, Schwarcz S, Colfax G, Bernstein K, Louie B, Dilley JW, Hecht J, Truong HM, Katz MH, McFarland W.

Sex Transm Infect. 2008 Nov;84(6):493-8. doi: 10.1136/sti.2008.031823.

PMID:
19028954
20.

Acute HIV infection - New York City, 2008.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2009 Nov 27;58(46):1296-9.

Supplemental Content

Support Center